The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
As hospitals restructure to gain sustainability in an era of reform, it is crucial for supply chain leaders to work collaboratively within health…
On-Demand Educational Webinars
Reducing variability in products, supplies, pharmaceuticals, and other cost drivers is key to achieving margins in Medicare payment. This webinar…
On-Demand Educational Webinars
Social responsibility is an emerging area of importance for all health care supply chain professionals to understand and participate in. This webinar…
Webcast
Supply chain is in the unique position, working with so many different disciplines within the hospital, that it is natural that they initiate conve
On-Demand Educational Webinars
This session explains the benefits of implementing the UDI such as immediate device status updates through collaboration with manufacturers and…
Webcast
Howard Mann, vice president, supply chain management at Cardiovascular Care Group discusses the basics of value analysis and value based purchasing